Investor Relations

SEC Filings

Document Details

Form
Filing Date
Jun 23, 2020
Document Date
Jun 22, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.